Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:ATCCode |
gptkb:J01CF03
|
| gptkbp:CASNumber |
61-32-5
|
| gptkbp:discoveredBy |
gptkb:Beecham_Group
|
| gptkbp:eliminationHalfLife |
0.5 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:hasMolecularFormula |
C17H19N2O6S
|
| https://www.w3.org/2000/01/rdf-schema#label |
Methicillin
|
| gptkbp:introducedIn |
1960
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:metabolism |
hepatic
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL1082
6472 6228 DB01014 |
| gptkbp:resistantTo |
MRSA (Methicillin-resistant Staphylococcus aureus)
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
nephritis
allergic reactions |
| gptkbp:status |
withdrawn from clinical use
|
| gptkbp:synonym |
Meticillin
|
| gptkbp:target |
penicillin-binding proteins
|
| gptkbp:UNII |
J9A4S2D0JV
|
| gptkbp:usedFor |
treatment of bacterial infections
|
| gptkbp:bfsParent |
gptkb:MRSA_infections
gptkb:MRSA_infection |
| gptkbp:bfsLayer |
7
|